Stock listing

NASDAQ:CING Cingulate Inc. Stock

Home listing (NASDAQ) of Cingulate Inc.

Follow Cingulate Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CING

$4.36 USD -0.03 (-0.7%)

Close on Oct 16, 2026

Cingulate Inc. logo
Ticker
NASDAQ:CING
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Sep 17, 2026

Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness

Aug 13, 2026

Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile

Aug 11, 2026

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

Jul 30, 2026

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Jul 2, 2026

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Jun 16, 2026

Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26

Jun 4, 2026

Cingulate Receives Complete Response Letter from FDA for CTx-1301

Jun 2, 2026

Cingulate Inc. Reports First Quarter 2026 Financial Results and Provides an Update of Commercial Readiness Efforts On Track for lead ADHD Asset CTx-1301

May 14, 2026

Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mar 18, 2026

All Cingulate Inc. news

Decks

Cingulate Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 75 in all · newest Sep 17, 2026 · oldest 2021
Decks
11 decks · latest October 2026

Where Cingulate Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CING · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CINGBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Cingulate Inc.